Mike Roof

This inventor holds 10 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 3 EPO patents. Top assignees: Boehringer Ingelheim Vetmedica Gmbh, United States of America, as Represented by the Secretary of Agriculture, Other. Active years: 2003-2023.

USPTO Granted Patents = 10 (Patent Applications = 1)

% Patents Active = 80.0

CIPO Patents = 3

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 58(Granted Patents)

Company Filing History:

6 out of 317

Boehringer Ingelheim Vetmedica Gmbh

patents

2 out of 1,215

United States of America, as Represented by the Secretary of Agriculture

patents

3 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2023

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11738077 - Immunogenic compositions comprising (2023-08-29),

2. 10994004 - Immunogenic compositions comprising (2021-05-04),

3. 10201599 - [object Object] (2019-02-12),

4. 9463231 - [object Object] (2016-10-11),

5. 8834891 - [object Object] (2014-09-16),

6. 8747859 - Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142 (2014-06-10),

7. 8741309 - Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142 (2014-06-03),

8. 7081342 - Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142 (2006-07-25),

9. 6660513 - Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142 (2003-12-09),

10. 6641819 - Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142 (2003-11-04),

Title: Mike Roof: Innovator in Veterinary Immunology

Introduction: Mike Roof is a prominent inventor based in Ames, Iowa, with a significant contribution to veterinary medicine through his innovative approach to immunogenic compositions. With ten patents to his name, Roof has been at the forefront of developing combination vaccines that enhance the health and wellbeing of swine, tackling diseases that affect livestock and their productivity.

Latest Patents: Among his latest patents, Mike Roof has developed immunogenic compositions aimed at reducing the incidence and severity of Porcine Respiratory Disease Complex (PRDC) caused by various pathogens. His inventions provide not only a combination vaccine effective against PRDC but also include immunological agents that target other disease-causing organisms in swine. Furthermore, he has designed kits that encapsulate these immunological agents for efficient treatment and prophylaxis.

Career Highlights: Roof has held key positions at Boehringer Ingelheim Vetmedica GmbH, where he has furthered his expertise in veterinary immunology. His career is marked by a dedication to improving animal health and productivity, significantly impacting the agricultural sector.

Collaborations: Throughout his career, Mike Roof has collaborated with several esteemed professionals, including William L. Mengeling and Ann C. Vorwald. These collaborations have fostered the development of cutting-edge solutions for the veterinary field, enhancing the effectiveness of immunological treatments for swine.

Conclusion: Mike Roof exemplifies innovation within the veterinary science domain through his commitment to developing effective immunogenic solutions. His extensive patent portfolio and collaborative efforts underscore his significant impact on improving animal health, which is crucial for the agricultural industry.